Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Paraproteinemias 1Nervous System Diseases 1Kidney Diseases 1Hematologic Diseases 1Autoimmune Diseases 1

Interventions

Bortezomib 3fludarabine 2Tacrolimus 2Cyclophosphamide 2ofatumumab 1fludarabine phosphate 1daratumumab 1birtamimab 1Zoledronic Acid 1Whole-Body Irradiation 1Vorinostat 1Thalidomide 1Stem Cell Transplantation 1Plasma Exchange 1Mycophenolic Acid 1Melphalan 1Lenalidomide 1KW-2478 1Hsp90 inhibitor KU757 1Etoposide 1Doxorubicin 1Dexamethasone 1Denosumab 1Cisplatin 1Calcium Dobesilate 1Busulfan 1Alemtuzumab 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Paraproteinemias × Plasma Exchange × Clear all
NCT01210716 2013-09-23

Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device

Fenwal, Inc.

Phase 3 Completed
37 enrolled 7 charts
Genitourinary

Autoimmune Diseases, Hematologic Diseases, Kidney Diseases, Nervous System Diseases, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡